The Technical AnalystExchange: XETRA Sector: Healthcare Industry: Medical Distribution
Medios AG Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.69% €13.92
Europe/Berlin / 2 mai 2024 @ 17:36
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 331.38 mill |
| EPS: | 0.790 |
| P/E: | 17.62 |
| Earnings Date: | May 07, 2024 |
| SharesOutstanding: | 23.81 mill |
| Avg Daily Volume: | 0.0379 mill |
| RATING 2024-05-02 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.90x |
| Company: PE 17.62 | sector: PE 19.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.44x |
| Company: PE 17.62 | industry: PE 39.79 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€-6.79 (-148.77%) €-20.71 |
| Date: 2024-05-02 |
| Expected Trading Range (DAY) |
|---|
|
€ 13.15 - 14.77 ( +/- 5.79%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €13.92 (-1.69% ) |
| Volume | 0.0467 mill |
| Avg. Vol. | 0.0379 mill |
| % of Avg. Vol | 123.28 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ILM1.DE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ILM1.DE
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
Last 10 Buy Signals
| Date | Signal | @ |
|---|---|---|
| NTRNUSD | May 2 - 12:56 | 0.720 |
| ANKRETHUSD | May 2 - 12:55 | 3 360.88 |
| ALPINEUSD | May 2 - 12:56 | 1.880 |
| ALPN | May 2 - 12:55 | $64.59 |
| CEG | May 2 - 12:55 | $185.61 |
| PI | May 2 - 12:54 | $158.69 |
| ETH2X-FLIUSD | May 2 - 12:50 | 21.51 |
| MMYT | May 2 - 12:51 | $68.73 |
| WAMPLUSD | May 2 - 12:49 | 21.23 |
| ARBUSD | May 2 - 12:49 | 1.028 |